EUVIMEDEUVIMED entdecken
Crossref

Ketamine alleviates fear memory and spatial cognition deficits in a PTSD rat model via the BDNF signaling pathway of the hippocampus and amygdala

Yue Teng, JiaYao Niu, Yang Liu, Han Wang, JinHong Chen, YuJia Kong, Ling Wang, Bo Lian, WeiWen Wang, HongWei Sun, KuiTao Yue

Behavioural Brain Research · 2024-02 · 459 · 114792

DOI: 10.1016/j.bbr.2023.114792 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Behavioural Brain Research, 2024-02. Verfasst von Yue Teng und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Psychology, Weifang Medical University, 7166# Baotong West Street, Weifang, Shandong 261053, PR China. Hauptthemen laut MEDLINE: Stress Disorders, Post-Traumatic, Ketamine, Cognitive Dysfunction. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Post-traumatic stress disorder (PTSD) is associated with traumatic stress experiences. This condition can be accompanied by learning and cognitive deficits. Studies have demonstrated that ketamine can rapidly and significantly alleviate symptoms in patients with chronic PTSD. Nonetheless, the effects of ketamine on neurocognitive impairment and its mechanism of action in PTSD remain unclear. METHODS: In this study, different concentrations of ketamine (5, 10, 15, and 20 mg/kg, i.p.) were evaluated in rat models of single prolonged stress and electrophonic shock (SPS&S). Expression levels of brain-derived neurotrophic factor (BDNF) and post-synaptic density-95 (PSD-95) in the hippocampus (HIP) and amygdala (AMG) were determined by Western blot analysis and immunohistochemistry. RESULTS: The data showed that rats subjected to SPS&S exhibited significant PTSD-like cognitive impairment. The effect of ketamine on SPS&S-induced neurocognitive function showed a U-shaped dose effect in rats. A single administration of ketamine at a dosage of 10-15 mg/kg resulted in significant changes in behavioral outcomes. These manifestations of improvement in cognitive function and molecular changes were reversed at high doses (15-20 mg/kg). CONCLUSION: Overall, ketamine reversed SPS&S-induced fear and spatial memory impairment and the down-regulation of BDNF and BDNF-related PSD-95 signaling in the HIP and AMG. A dose equal to 15 mg/kg rapidly reversed the behavioral and molecular changes and promoted the amelioration of cognitive dysfunction. The enhanced association of BDNF signaling with PSD-95 effects could be involved in the therapeutic efficiency of ketamine for PTSD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stress Disorders, Post-TraumaticKetamineCognitive DysfunctionHumansRatsAnimalsBrain-Derived Neurotrophic FactorHippocampusAmygdalaCognitionSignal TransductionFearDisease Models, Animal

Stichwörter der Autor:innen

Brain-derived neurotrophic factorKetamineNeurocognitive functionPost-traumatic stress disorderPostsynaptic density protein 95

Substanzen

Brain-Derived Neurotrophic FactorKetamine

Autor:innen und Institutionen

  • School of Psychology, Weifang Medical University, 7166# Baotong West Street, Weifang, Shandong 261053, PR China.
  • School of Clinical Medicine, Weifang Medical University, 7166# Baotong West Street, Weifang, Shandong 261053, PR China.
  • School of Continuing Education, Weifang Medical University, 7166# Baotong West Street, Weifang, Shandong 261053, PR China.
  • School of Public Health, Weifang Medical University, 7166# Baotong West Street, Weifang, Shandong 261053, PR China.
  • Clinical Competency Training Center, Medical experiment and training center, Weifang Medical University, 7166# Baotong West Street, Weifang, Shandong 261053, PR China.
  • Department of Bioscience and Technology, Weifang Medical University, 7166# Baotong West Street, Weifang, Shandong 261053, PR China.

Zitieren

APA

Teng, Y., Niu, J., Liu, Y., Wang, H., Chen, J., Kong, Y., Wang, L., Lian, B., Wang, W., Sun, H., & Yue, K. (2024). Ketamine alleviates fear memory and spatial cognition deficits in a PTSD rat model via the BDNF signaling pathway of the hippocampus and amygdala. Behavioural Brain Research, 459, 114792. https://doi.org/10.1016/j.bbr.2023.114792

Vancouver

Teng Y, Niu J, Liu Y, Wang H, Chen J, Kong Y, et al. Ketamine alleviates fear memory and spatial cognition deficits in a PTSD rat model via the BDNF signaling pathway of the hippocampus and amygdala. Behavioural Brain Research. 2024;459:114792. doi:10.1016/j.bbr.2023.114792

BibTeX
@article{Teng2024,
  author = {Teng, Yue and Niu, JiaYao and Liu, Yang and Wang, Han and Chen, JinHong and Kong, YuJia and Wang, Ling and Lian, Bo and Wang, WeiWen and Sun, HongWei and Yue, KuiTao},
  title = {Ketamine alleviates fear memory and spatial cognition deficits in a PTSD rat model via the BDNF signaling pathway of the hippocampus and amygdala},
  journal = {Behavioural Brain Research},
  year = {2024},
  volume = {459},
  pages = {114792},
  doi = {10.1016/j.bbr.2023.114792}
}
Kostenlos starten →